AI

Additio Investment Group

Europe, Catalonia, Spain, Barcelona

Description

Additio Investment Group supports high-integrity entrepreneurs with the potential to build great businesses in Healthcare and Life Sciences.

Investor Profile

Additio Investment Group has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United Kingdom (75%)
  • Sweden (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Additio Investment Group frequently co-invest with?

Vulpes Investment Management Pte Ltd
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Oxford Investment Consultants LLP
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 3
PI
Europe, NA - Jersey, Jersey, St. Helier
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 3
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 1

What are some of recent deals done by Additio Investment Group?

Orthox Ltd.

Abingdon, Oxfordshire, United Kingdom

Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.

BiotechnologyHealth CareMedical Device
Series AFeb 9, 2022
Amount Raised: $12,449,896
Oxford Endovascular

Oxford, Oxfordshire, United Kingdom

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

BiotechnologyHealth CareMedical
Series AApr 8, 2021
Amount Raised: $9,888,195
Gedea Biotech

Lund, Skane Lan, Sweden

Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.

BiotechnologyHealth Care
Series AJun 1, 2020
Orthox Ltd.

Abingdon, Oxfordshire, United Kingdom

Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.

BiotechnologyHealth CareMedical Device
Series AApr 3, 2016
Amount Raised: $4,300,000